| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 103.321 | 98.445 | - | 119.507 | 168.376 | 199.783 | 187.730 | 214.170 | 215.291 | 252.025 |
| Total Income - EUR | 103.325 | 98.445 | - | 120.168 | 173.917 | 209.127 | 193.762 | 224.478 | 223.070 | 257.359 |
| Total Expenses - EUR | 99.602 | 97.379 | - | 109.535 | 155.604 | 179.764 | 174.574 | 214.695 | 211.932 | 238.527 |
| Gross Profit/Loss - EUR | 3.723 | 1.067 | - | 10.633 | 18.313 | 29.363 | 19.189 | 9.782 | 11.137 | 18.832 |
| Net Profit/Loss - EUR | 2.970 | 896 | - | 9.431 | 16.661 | 27.535 | 17.290 | 7.936 | 8.987 | 15.222 |
| Employees | 4 | 4 | - | 2 | 2 | 2 | 2 | 2 | 2 | 2 |
Check the financial reports for the company - Marcomed Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 11.978 | 8.178 | - | 1.827 | 3.167 | 3.030 | 2.729 | 10.950 | 8.479 | 6.924 |
| Current Assets | 21.744 | 29.868 | - | 40.911 | 60.376 | 80.209 | 119.981 | 78.688 | 110.320 | 118.586 |
| Inventories | 3.616 | 6.774 | - | 11.663 | 17.713 | 44.125 | 46.023 | 16.577 | 23.871 | 50.789 |
| Receivables | 15.664 | 18.451 | - | 27.692 | 41.986 | 35.640 | 43.302 | 53.736 | 67.389 | 52.332 |
| Cash | 2.463 | 4.642 | - | 1.556 | 655 | 443 | 30.656 | 8.374 | 19.061 | 15.464 |
| Shareholders Funds | 12.574 | 13.342 | - | 22.746 | 29.717 | 40.344 | 29.815 | 8.268 | 7.781 | 22.960 |
| Social Capital | 135 | 134 | - | 129 | 126 | 124 | 121 | 122 | 121 | 121 |
| Debts | 21.148 | 24.704 | - | 19.992 | 33.826 | 42.895 | 92.895 | 81.370 | 111.018 | 102.550 |
| Income in Advance | 0 | 0 | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "4774 - 4774" | |||||||||
| CAEN Financial Year |
4774
|
|||||||||
Comments - Marcomed Srl